James Pan, PhD

-Twenty-five years of experience in drug R&D，in the areas of small molecule drugs, antibodies and cell therapies
-Co-founded several startups, including Exacis Biotherapeutics, iPSC-derived developing cancer cell therapies using mRNA technology
-Participated in a number of financing activities
-Served as VP at the Centre for the Commercialization of Antibody and Biologics in Toronto, Canada
-Served as Director of Therapeutics at the CF Institute for Breast Cancer Research, Princess Margaret Hospital, UHN, Toronto, Canada
-Held various research and management positions at Genentech and Affinium Pharmaceuticals and the Toronto Recombinant Antibody Centre
-Received PhD in Molecular and Medical Genetics from University of Toronto and conducted postdoctoral research at University of Toronto and the University of Michigan
-Published more than 50 scientific papers in the scientific journals with over 10,000 citations. Inventor and co-inventor of more than 60 patents and patent applicat